Clinical therapeutics
-
Clinical therapeutics · Oct 2015
ReviewTeriflunomide: a once-daily oral medication for the treatment of relapsing forms of multiple sclerosis.
The purpose was to summarize US prescribing information for teriflunomide in the treatment of patients with relapsing forms of multiple sclerosis (RMS), with reference to clinical efficacy and safety outcomes. ⋯ Clinical evidence suggests that teriflunomide is an effective therapeutic choice for patients with RMS, both as an initial treatment and as an alternative for patients who may have experienced intolerance or inadequate response to a previous or current disease-modifying therapy.